Conversations in Interventional Cardiology - Enhanced Radiation Protection: A Multi-Society Call to Action

Description

This conversation discusses the JSCAI article, "SCAI/ASE/HRS/SIR/SVS Expert Consensus Statement on Enhanced Radiation Protection: Time for Mandatory and Urgent Action."

In this episode of SCAI Conversations in Interventional Cardiology, experts discuss the multisociety consensus statement calling for the urgent adoption of enhanced radiation protection technologies to reduce occupational radiation exposure and orthopedic injuries among fluoroscopy laboratory personnel. Moderator Dean Kereiakes, presenting author David Rizik, and panelists Carine Werner, Kenneth Rosenfield, and Dipti Ichhaporia explore the evidence supporting enhanced radiation protection, the barriers to implementation, and the regulatory and policy changes needed to better safeguard today's cardiovascular care teams.

Read the full manuscript in JSCAI.

Faculty

	Dean J. Kereiakes, MD, MSCAI Moderator		David G. Rizik, MD, MSCAI Presenting Author
	Dipti Itchhaporia, MD Panelist		Kenneth Rosenfield, MD, MSCAI Panelist
	Carine Werner Arizona State Senator, Panelist

Learning Objectives

Upon completion of this activity, participants will be able to:

Evaluate the major occupational health hazards associated with fluoroscopy use—including radiation related cancers, cataracts, reproductive risks, and musculoskeletal injuries linked to heavy PPE.
Understand the ALARA principle and identify how modern ERPDs redefine what is "reasonably achievable" exposure in contemporary practice.
Identify key barriers to implementation, as well as institutional, regulatory, and professional society responsibilities for improving safety. Understand how SCAI and its partner societies are advocating for and working to achieve ALARA+

Acknowledgement of Commercial Support

This activity is supported by unrestricted educational grants from Egg Medical, Rampart, Salus Scientific and Texray.

Disclosures

Individuals in control of content reported the following relevant financial relationships with ineligible companiesduring the content development process for this activity. All relevant financial relationships were mitigated beforethe start of the activity.

Planner:
Alexandra Lansky: Boston Scientific - speaker.

Faculty:
Dipti Itchhaporia: No relevant financial relationships with ineligible companies.

Dean Kereiakes: Egg Medical - stock options.

David Rizik: ECLS, Inc. - consultant.

Kenneth Rosenfield: Philips - Advisory Board; Radiaction - stock options; Salus Scientific - stock options.

Carine Werner: No relevant financial relationships with ineligible companies.

Staff:
Kristen Perry and Amanda Pettyjohn: No relevant financial relationships with ineligible companies.

Continuing Education Information

This activity is not certified for accredited continuing education credits.

Summary

Availability:

On-Demand

Access expires on Sep 29, 2029

Cost:

FREE

Credit Offered:

0.75 Participation Credit